Evidence map›Paper›PMID 26951092›Full record

ArticleBMC cancer2016

Snail heterogeneity in clear cell renal cell carcinoma.

Laura Zaldumbide, Asier Erramuzpe, Rosa Guarch, Rafael Pulido, Jesús M Cortés, José I López

Abstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Precise Immunodetection of PTEN Protein in Human Neoplasia.Cold Spring Harbor perspectives in medicine · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura ZaldumbideDepartment of Pathology, Cruces University Hospital, University of the Basque Country (UPV/EHU), Plaza de Cruces s/n, 48903, Barakaldo, Bizkaia, Spain. laura.zaldumbideduenas@osakidetza.eus.
Asier ErramuzpeQuantitative Biomedicine Unit, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain. asier.erramuzpe@gmail.com.
Rosa GuarchDepartment of Pathology, Complejo Hospitalario de Navarra-Hospital Virgen del Camino, Pamplona, Navarra, Spain. rosa.guarch.troyas@cfnavarra.es.
Rafael PulidoBiomarkers in Cancer Unit, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain. rpulidomurillo@gmail.com.
Jesús M CortésQuantitative Biomedicine Unit, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain. jesus.m.cortes@gmail.com.
José I LópezDepartment of Pathology, Cruces University Hospital, University of the Basque Country (UPV/EHU), Plaza de Cruces s/n, 48903, Barakaldo, Bizkaia, Spain. joseignacio.lopez@osakidetza.eus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntratumor heterogeneity may be responsible of the unpredictable aggressive clinical behavior that some clear cell renal cell carcinomas display. This clinical uncertainty may be caused by insufficient sampling, leaving out of histological analysis foci of high grade tumor areas. Although molecular approaches are providing important information on renal intratumor heterogeneity, a focus on this topic from the practicing pathologist' perspective is still pending.

methodsFour distant tumor areas of 40 organ-confined clear cell renal cell carcinomas were selected for histopathological and immunohistochemical evaluation. Tumor size, cell type (clear/granular), Fuhrman's grade, Staging, as well as immunostaining with Snail, ZEB1, Twist, Vimentin, E-cadherin, β-catenin, PTEN, p-Akt, p110α, and SETD2, were analyzed for intratumor heterogeneity using a classification and regression tree algorithm.

resultsCell type and Fuhrman's grade were heterogeneous in 12.5 and 60 % of the tumors, respectively. If cell type was homogeneous (clear cell) then the tumors were low-grade in 88.57 % of cases. Immunostaining heterogeneity was significant in the series and oscillated between 15 % for p110α and 80 % for Snail. When Snail immunostaining was homogeneous the tumor was histologically homogeneous in 100 % of cases. If Snail was heterogeneous, the tumor was heterogeneous in 75 % of the cases. Average tumor diameter was 4.3 cm. Tumors larger than 3.7 cm were heterogeneous for Vimentin immunostaining in 72.5 % of cases. Tumors displaying negative immunostaining for both ZEB1 and Twist were low grade in 100 % of the cases.

conclusionsIntratumor heterogeneity is a common event in clear cell renal cell carcinoma, which can be monitored by immunohistochemistry in routine practice. Snail seems to be particularly useful in the identification of intratumor heterogeneity. The suitability of current sampling protocols in renal cancer is discussed.

Indexed as

AdultAgedAged, 80 and overBiomarkersCarcinoma, Renal CellFemaleHumansImmunohistochemistryKidney NeoplasmsMaleMiddle AgedNeoplasm GradingSnail Family Transcription FactorsBiomarkersSnail Family Transcription Factors

Identifiers

PMID26951092
PMCPMC4782341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.